Target intelligence / Profile preview

Phosphoglycerate kinase 1 (PGK1)

Target
PGK1
Molecular classification
Enzyme, Kinase, Moonlighting protein
01

Overview

Phosphoglycerate kinase 1 (PGK1) is a highly conserved, ubiquitously expressed enzyme essential for cellular energy metabolism. It catalyzes the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate in glycolysis, generating ATP—the first substrate-level phosphorylation step of the glycolytic pathway[3][4][5]. Besides its canonical metabolic function, PGK1 is a moonlighting protein with diverse activities; it acts as a cofactor for DNA polymerase alpha in DNA replication, is secreted from tumor cells to modulate angiogenesis via angiostatin production, and functions as a protein kinase in mitochondria to regulate metabolic flux in response to oncogenic and hypoxic signaling[1][4][5]. Dysregulation of PGK1 is associated with inherited enzymopathies (including hemolytic anemia and myopathy) and is strongly implicated in cancer progression, where it supports tumor cell proliferation, invasion, and chemoresistance through metabolic and non-metabolic mechanisms[1][2][5].

Other names
PGKAMIG10OK/SW-cl.110PRP 2Cell migration-inducing gene 10 proteinPrimer recognition protein 2HEL-S-68pepididymis secretory sperm binding protein Li 68p
02

Mechanism of action

PGK1 generates ATP via phosphate transfer from 1,3-diphosphoglycerate to ADP. It inhibits the pyruvate dehydrogenase complex (via mitochondrial protein kinase activity on PDK1). PGK1 promotes or inhibits angiogenesis through the regulation of angiostatin formation.

03

Biological functions

Glycolysis (ATP generation)GluconeogenesisRegulation of angiogenesisRegulation of metabolic reprogramming in cancerDNA replication (as a primer recognition protein)Protein kinase signaling within mitochondria
04

Disease associations

CancerHemolytic anemia (phosphoglycerate kinase deficiency)Neurological impairmentMyopathies
05

Safety considerations

Oncogenic modulation: Overexpression promotes tumor growth, metastasis, and drug resistanceNeurological and muscular toxicity risk if inhibited systemically due to essential role in energy metabolism; genetic deficiency causes anemia and neuromuscular symptoms
06

Interacting drugs

Antiviral and anticancer nucleotide analogs (as PGK1 is required for their phosphorylation/intracellular activation)

1 more in the full profile.

07

Biomarkers

High PGK1 expression as a biomarker for tumor progression, aggressiveness, and poor prognosis in several cancersPGK1 mutations/deficiency as a biomarker for phosphoglycerate kinase deficiency syndromes (e.g., hemolytic anemia, myopathy)

Beyond the preview

Go deeper on Phosphoglycerate kinase 1 (PGK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoglycerate kinase 1 (PGK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call